SUMATRIPTAN SUCCINATE

CAS No.
103628-48-4
CCD No.
CCD00179562
Formula
C14 H21 N3 O2 S . C4 H6 O4
MolWeight
413.492

Basic Information

Product Name: SUMATRIPTAN SUCCINATE
CAS: 103628-48-4
English Synonyms: 3-[2-(DIMETHYLAMINO)ETHYL]-N-METHYL-1H-INDOLE-5-METHANESULFONAMIDE,BUTANEDIOATE(1:1) ; IMITREX ; 1-(3-(2-DIMETHYLAMINOETHYL)-1H-INDOL-5-YL)-N-METHYL-METHANESULFONAMIDE SUCCINATE ; SUMATRIPTAN (SUCCINATE) ; SUMATRIPTAN SUCCINATE ; SUMITREX ; SUMINAT ; IMIGRAN ; 3-[2-(DIMETHYLAMINO)ETHYL]-1H-INDOL-5-YL-N-METHYLMETHANESULFONAMIDE SUCCINATE ; BUTANEDIOIC ACID, COMPOUND WITH 3-[2-(DIMETHYLAMINO)ETHYL]-N-METHYL-1H-INDOLE-5-METHANESULFONAMIDE (1:1) ; GR 43175C ; MITREX ; GR-43175 SUCCINATE ; SUCCINIC ACID-1-(3-[2-(DIMETHYLAMINO)ETHYL]-1H-INDOL-5-YL)-N-METHYLMETHANESULFONAMIDE (1:1) ; SUMATRIPTAN ; 3-[2-(DIMETHYLAMINO)ETHYL]-N-METHYL-1H-INDOLE-5-METHANESULFONAMIDE SUCCINATE
MDL Number.: MFCD00902856
H bond acceptor: 5
H bond donor: 2
Smile: CNS(=O)(=O)Cc1ccc2c(c1)c(c[nH]2)CCN(C)C.C(CC(=O)O)C(=O)O
InChi: InChI=1S/C14H21N3O2S.C4H6O4/c1-15-20(18,19)10-11-4-5-14-13(8-11)12(9-16-14)6-7-17(2)3;5-3(6)1-2-4(7)8/h4-5,8-9,15-16H,6-7,10H2,1-3H3;1-2H2,(H,5,6)(H,7,8)
InChiKey: InChIKey=PORMUFZNYQJOEI-UHFFFAOYSA-N

Property

Comments: BIOCHEM/PHYSIOL ACTIONS: SUMATRIPTAN SUCCINATE IS A 5-HT1 SEROTONIN RECEPTOR AGONIST
FOR SYSTEM SUITABILITY
GENERAL DESCRIPTION: THIS PRODUCT IS PROVIDED AS DELIVERED AND SPECIFIED BY THE ISSUING PHARMACOPOEIA. ALL INFORMATION PROVIDED IN SUPPORT OF THIS PRODUCT, INCLUDING MSDS AND ANY PRODUCT INFORMATION LEAFLETS HAVE BEEN DEVELOPED AND ISSUED UNDER THE AUTHORITY OF THE ISSUING PHARMACOPOEIA. FOR FURTHER INFORMATION AND SUPPORT PLEASE GO TO THE WEBSITE OF THE ISSUING PHARMACOPOEIA
OTHER NOTES: SALES RESTRICTIONS MAY APPLY

Safety information

Symbol: GHS05 GHS05
Signal word: Danger
Hazard statements: H318
Precautionary statements: P280-P305 + P351 + P338
hazard symbol: Xi
Risk Code: R:41
Safe Code: S:26-39
WGK Germany: 3

* If the product has intellectual property rights, a license granted is must or contact us.